Global Ophthalmic Viscoelastic Devices (OVDs) Market by Type (Cohesive Ophthalmic Viscoelastic Devices (OVD) and Dispersive Ophthalmic Viscoelastic Devices (OVD)), By Application (Vitreoretinal Surgery, Glaucoma Surgery, Cataract Surgery, and Corneal Transplantation), By End User (Hospitals, Ophthalmology Clinics, and Others), and Geography

 

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Global Ophthalmic Viscoelastic Devices (OVDs) Market was valued at $2,341 million in 2020 and is anticipated to grow at $3,227 million by 2027 recording a CAGR of 4.14% during the forecast period 2021-2027. Ophthalmic Viscoelastic Devices (OVDs) Market in a variety of eye surgeries, including cataract surgery, glaucoma surgery, and others. These devices help to protect the fragile ocular tissues by producing pressure in the anterior chamber, compartmentalising inside the eye, and allowing patients to have a speedier and safer surgery with a faster recovery. Depending on the situation, ophthalmologists use a variety of ophthalmic instruments. As a result, ophthalmic viscoelastic devices serve a critical role in the treatment of various eye diseases during surgery all over the world. Ophthalmic viscoelastic devices (OVDs) are the medical devices that are used in the cataract surgery in order to create and maintain the space in the anterior chamber of the eye during phacoemulsification and implantation of an intraocular lens (IOL). There are various types of the ophthalmic viscoelastic devices such as dispersive ophthalmic viscoelastic device and cohesive ophthalmic viscoelastic device. Most of the ophthalmic viscoelastic devices (OVDs) contain sodium hyaluronate (NaHA) or hydroxypropyl methylcellulose (HPMC). The surge in government initiatives aimed at establishing rules to control the global increase in vision impairment is pressuring major manufacturers to release new ophthalmic products. Other factors that contribute to the growth of the Ophthalmic Viscoelastic Devices Market include an increase in the prevalence of cataracts and glaucoma, an increase in the number of eye procedures performed, and an increase in the geriatric population. The Ophthalmic Viscoelastic Devices Market is also expected to rise due to an increase in the adoption of viscoelastic devices around the world.  

Ophthalmic Viscoelastic Devices Ovds Market Summary

Study Period

2023-29

Base Year

2022

CAGR

4.14%

Largest Market

North America

Fastest Growing Market

Asia-Pacific
Growth

Increase in the prevalence of eye diseases and rise in the number of cataract and glaucoma surgeries are driving the growth of ophthalmic viscoelastic devices (OVDs) market. The favorable reimbursement policies for surgeries using ophthalmic viscoelastic devices (OVDs) and strategic approach of the manufacturers help them sustain the growth and expansion in the market. The collaborations, mergers and acquisitions among vendors are helping to drive the R&D activities which are expected to create the market growth. However, the availability of alternate therapies, poor healthcare infrastructure, and the lack of awareness among the healthcare fraternity may hinder the growth of the ophthalmic viscoelastic devices (OVDs) market over the forecast period.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Ophthalmic Viscoelastic Devices Ovds Market Segmentation

By Type
  • Cohesive ophthalmic viscoelastic devices (OVD)
  • Dispersive ophthalmic viscoelastic devices (OVD)
By Application
  • Vitreoretinal Surgery
  • Glaucoma Surgery
  • Cataract Surgery
  • Corneal Transplantation
By End User
  • Hospitals
  • Ophthalmic clinics
  • Others
Geography
North America
  • US
  • Canada
Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe
Asia-Pacific
  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific
Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
Middle East and Africa (MEA)
  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

[urltag url='request-table-of-content']

  • Johnson & Johnson ((U.S)
  • Alcon Laboratories Inc. (Switzerland)
  • Bausch & Lomb (U.S)
  • Carl Zeiss AG (Germany)
  • Rayner Company (UK)
  • Bohus BioTech AB (Sweden)
  • Lifecore Biomedical LLC (U.S)